南微医学收盘上涨4.04%，滚动市盈率20.50倍，总市值116.97亿元

Company Overview - Nanwei Medical's main business includes the research, manufacturing, and sales of minimally invasive medical devices, with key products such as endoscopic diagnostic instruments, microwave ablation equipment, and disposable endoscopes [1] - The company is one of the major manufacturers of endoscopic diagnostic instruments in China, recognized for its early start in the industry, strong innovation capabilities, rich product lines, and significant scale advantages [1] Financial Performance - For Q1 2025, the company reported a revenue of 699 million yuan, representing a year-on-year increase of 12.75% [2] - The net profit for the same period was 161 million yuan, showing a year-on-year growth of 12.18% [2] - The sales gross margin stood at 65.69% [2] Market Position - As of May 6, the closing price of Nanwei Medical was 62.27 yuan, with a PE ratio of 20.50, marking a new low in the past 20 days [1] - The company's total market capitalization is 11.697 billion yuan [1] - In comparison to the industry, the average PE ratio for the medical device sector is 48.90, with a median of 36.41, placing Nanwei Medical at the 49th position in the industry ranking [1] Shareholding Structure - As of Q1 2025, a total of 17 institutions hold shares in Nanwei Medical, including 11 funds, 4 other institutions, and 2 social security funds, with a total holding of 106.4733 million shares valued at 7.017 billion yuan [1]